摘要:
A method, in a base station subsystem (10), of allocating radio resources to mobile stations (20) in a wireless communication system (1) involves the base station subsystem (10) assigning a respective Temporary Block Flow (TBF) to each mobile station (20) in a cell (40) in the communication system (1), and then assigning to each TBF a Temporary Flow Identity (TFI), at least one Packet Data Channel (PDCH), and an Uplink State Flag (USF) if the TBF is an uplink TBF. The base station subsystem (10) then selects different training sequences from a plurality of available training sequences and assigns a respective different selected training sequence to two or more TBFs wherein these two or more TBFs share the same assigned Temporary Flow Identity (TFI), the same assigned Packet Data Channel (PDCH), and/or the same assigned Uplink State Flag (USF) if the TBF is an uplink TBF.
摘要:
A method, in a base station subsystem (10), of allocating radio resources to mobile stations (20) in a wireless communication system (1) involves the base station subsystem (10) assigning a respective Temporary Block Flow (TBF) to each mobile station (20) in a cell (40) in the communication system (1), and then assigning to each TBF a Temporary Flow Identity (TFI), at least one Packet Data Channel (PDCH), and an Uplink State Flag (USF) if the TBF is an uplink TBF. The base station subsystem (10) then selects different training sequences from a plurality of available training sequences and assigns a respective different selected training sequence to two or more TBFs wherein these two or more TBFs share the same assigned Temporary Flow Identity (TFI), the same assigned Packet Data Channel (PDCH), and/or the same assigned Uplink State Flag (USF) if the TBF is an uplink TBF.
摘要:
There is provided compounds of formula I, wherein the dotted line, X1, X2, X3, A, Y1, Y2, Y3, Y4, Z1, Z2, R2 and R3 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful as selective agonists of the AT2 receptor, and thus, in particular, in the treatment of inter alia gastrointestinal conditions, such as dyspepsia, IBS and MOF, and cardiovascular disorders.
摘要:
There is provided a use of a compound of formula (I), wherein R1, R2, R3 and R4 have meanings given in the description, and pharmaceutically-acceptable salts thereof, for the manufacture of a medicament for the treatment of a disease in which inhibition of the activity of a lipoxygenase (e.g. 15-lipoxygenase) is desired and/or required, and particularly in the treatment of inflammation.
摘要:
There is provided compounds of formula I, wherein the dotted line, X1, X2, X3, A, Y1, Y2, Y3, Y4, Z1, Z2, R2 and R3 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful as selective agonists of the AT2 receptor, and thus, in particular, in the treatment of inter alia gastrointestinal conditions, such as dyspepsia, IBS and MOF, and cardiovascular disorders.
摘要:
Compounds of the formula I: wherein R1, R2, X and N are as defined in the specification; E is N, CH; A′ and A″ are terminal groups as defined in the specification. The compounds have utility as HIV-1 protease inhibitors.
摘要:
There is provided a compound of formula I, wherein R1a, R1b, X, Y1, Y2, Y3, Y4, Z1, Z2, R2 and R3 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful as selective agonists of the AT2 receptor, and thus, in particular, in the treatment of inter alia gastrointestinal conditions, such as dyspepsia, IBS and MOF, and cardiovascular disorders.
摘要:
Compounds of the formula I: wherein R1, R2, X and N are as defined in the specification; E is N, CH; A′ and A″ are terminal groups as defined in the specification. The compounds have utility as HIV-1 protease inhibitors.
摘要:
An opening arrangement on a packing container of the type which comprises a pouring opening 6 formed in the upper side of the container. The opening arrangement comprises a cover strip 8 and a pouring edge strip 7 arranged between the cover strip 8 and the packing container. To make possible the reclosure of the pouring opening 6 the cover strip 8 is provided with a gripping strip 9' sealed to its underside which preferably has a free gripping edge 9" facilitating the hooking of the cover strip 8 to the pouring tab 7.
摘要:
There is provided a compound of formula I, wherein R1a, R1b, X, Y1, Y2, Y3, Y4, Z1, Z2, R2 and R3 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful as selective agonists of the AT2 receptor, and thus, in particular, in the treatment of inter alia gastrointestinal conditions, such as dyspepsia, IBS and MOF, and cardiovascular disorders.